
How Slutty Vegan founder Pinky Cole lost control of her business—and took it back
This is an abridged transcript of an interview from Rapid Response, hosted by Bob Safian, the former editor-in-chief of Fast Company. From the team behind the Masters of Scale podcast, Rapid Response features candid conversations with today's top business leaders navigating real-time challenges. Subscribe to Rapid Response wherever you get your podcasts to ensure you never miss an episode.
We last spoke on stage at the Masters of Scale Summit in October of 2024. And things seemed to be humming—you had new stores, there were some high-profile collaborations, and we talked about investors, including Shake Shack founder Danny Meyer, a great mentor to have. And then everything turned a little bit. Take us back to last fall, how you were feeling about the business, and what unfolded as the year finished out.
I want to preface this conversation as a cautionary tale for founders. When I talk about my journey and the things that I've been through, I have seen a massive amount of success. I have gotten the title of every single magazine you could imagine. I've graced all the lists. I've gotten all of the things. But what I also realized is that it didn't come without challenges. And just like all things go up, some things do go down.
And when I met with you, Bob, I was in the middle of one of the most powerful yet crunching seasons of my life. Here it is: I'm still making double-digit millions, doing very well as an organization by way of revenue, but operationally, I was not sound. And because I was not sound, the ship was sinking. It started off with a slow sink, and then eventually that ship went all the way under. And there's no way to save a ship that's got 10 holes in it. No matter how many buckets you try to get to push the water out, whatever effort that you try to do, there was no way to save it. I went from having challenges with cash flow. You know how it goes, Bob. If the cash flow doesn't make sense, then the business can't make sense. And all of these things happen really, really fast.
Some people think that it's like a slow roll. No, it's just like one day you're good, and the next day you're not. And after I did the taping with you, it got real. And real as in I had to file for an assignment for the benefit of creditors. And for the people who are listening to this: If you don't know what that is, that is like bankruptcy's fourth cousin far removed. It is an insolvency proceeding that happens outside of court when a company or organization, the revenue doesn't speak to the debt that it has. My debt was above the revenue. Here I am, overall, I got about $20 million in debt. I'm burning $100,000 every single week. That is taxing on any entrepreneur, especially when you have a board that, at this point, they're like: 'Okay, how did we get here? What happened?'
And when I look back over everything, I wasn't in the company day to day. I'm the mascot. I'm the thought leader. I'm doing all these things, putting people in position. We did a lot of great things collectively as an organization, but there were some learning curves there. And what I've learned from this experience is that talent is the root of all evil or is the foundation for your success. You want to have a really good organization? You've got to have really good talent. And I'm not just talking about people that look good on a résumé. I'm talking about people who can roll with the punches, who are great problem-solvers, who can look at an organization and identify ways in which to make it better. It's not enough just to say that you worked at a company that was successful. No, you've got to come in this one and make sure that this one is successful. A lot of learning there, to say the least.
I want to ask you a couple of questions about that turn that happened—you mentioned losing $100,000 a week. Now you could say, 'Well, that's the plan. We're going to invest $5 million a year to build a brand.' That it's part of what the strategy is. It doesn't sound like that's where the losses were coming from. Was there a single primary business problem, or was it like a group of things?
It was a group of things. The model has always been proven; we have a good business model. We have a cult following. People love the brand. That wasn't what it was. What happened is, in the middle of the pandemic is when we got our rise. Could you imagine we raised $25 million and then inflation is through the roof? What would cost $600,000 to open up a Slutty Vegan cost almost $1 million to open up a Slutty Vegan. We opened up 14. We were very ambitious with our goals. On the surface, the business was very buttoned up, very organized. But the reality of it is, we were a bit above our britches. Our C-suite was super expensive. We were paying top dollar for construction and opening up locations. We had one location in particular where it took us four months beyond the completion date to get opened because of permitting—obviously, that cost money. All of the things just came together, and it became a domino effect.
I had three babies in three years. I had a baby in '21, I had a baby in '22, and I had a baby in '23. And I got married, and I'm doing all of these things. And when I started this company, I never coined myself as an operator. I'm not a restaurant operator. I'll tell the truth. But this has always been a passion project for me, so what I do very well is, I market my business very well. I know how to connect the dots, and I can bring people together. So I brought in people who I thought can manage the operations. And did they do good work? Sure. I'm a professional, sure. But at the end of the day, the level of acumen that we need for the momentum that we have, I needed somebody else. But I want to say that I needed that to happen at the moment in time in which it happened, because it gave me the opportunity to, one, clear my cap table, two, clear the debt. And then it gave me an opportunity to buy my company back and rewrite my story.
The one thing about entrepreneurship is that nobody tells you that it has to be a straight line. You're going to get some curves, there's going to be some speed bumps, and you're going to flip over a couple of times. But as long as you keep driving, that is where you get the juice. And I've been thirsty for this new juice of 2.0 in Slutty Vegan, and that's bringing in a new president, bringing in a new accounting firm, bringing in a new HR team, even down to the damn assistant—everything new. And I wanted to be able to rewrite the story in a way where not only just I could feel good about myself aspirationally, but founders around the world can look at my story and know what to do, and know what not to do, because Pinky went through it.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
World Liberty Financial token valued at $0.20 in Trump crypto project's ALT5 treasury deal
World Liberty Financial's deal with ALT5 Sigma Corporation has put a value on WLFI, the Trump-backed DeFi project's token, for the first time since its sale last year. On Monday, ALT5 announced plans to pivot to become a so-called crypto treasury company, selling 200,000 new shares and using the proceeds to buy up the $1.5 billion worth of WLFI. The firm will swap half of the newly-issued shares directly for WLFI held by World Liberty Financial in a deal that values the token at $0.20, Matt Morgan, ALT5's chief investment officer, told DL News. It's not clear if World Liberty Financial is the only participant swapping WLFI tokens for shares. The firm said that several other unnamed institutional investors and venture capital firms participated in the share sale. It's the first time that WLFI has received a valuation since World Liberty Financial sold $550 million worth tokens to investors between October and March. At the time, investors paid varying prices for WLFI depending on how early in the sale they bought it. Large WLFI holders include Tron founder Justin Sun, who bought $75 million worth during the token sale. On its launch, WLFI was programmed so that buyers couldn't trade it, meaning that there was no way for the market to value the token. Conflict of interest The deal also highlights the growing crypto treasury company trend. Michael Saylor's Strategy was a trailblazer in this regard. The firm has issued debt or shares to buy Bitcoin since 2020, a ploy which has seen its shares skyrocket by over 3,500% since. Over the past year, a new wave of crypto treasury companies have copied Saylor's playbook on the back of a favourable crypto regulatory environment under the Trump administration. Many of these companies issue debt or shares to buy up their cryptocurrency of choice, and often emerge through reverse mergers with struggling publicly traded companies. Sometimes there's a conflict of interest between the treasury companies and the issuers of the crypto asset they buy. Tron Inc, a crypto treasury company that says it will buy up TRX, the native token of the Tron blockchain, has Weike Sun on its board, the father of Justin Sun. The firm listed the father-son relationship among its potential conflicts of interest in its S-3 filing last month. As a part of ALT5's crypto treasury swerve, the firm added several World Liberty Financial executives and backers to its board of directors. They include World Liberty Financial CEO Zach Witkoff, the project's COO Zak Folkman, and Eric Trump, President Donald Trump's son. All three new appointees hold WLFI and therefore have a financial interest in the token's value. Morgan said he's not at liberty to comment on matters that may involve commercially sensitive information relating to his role or ALT5 when asked about the potential conflict of interest of the board appointments. Trading the token The WLFI token is designed to govern World Liberty Financial. Those who hold the token can vote on changes to the protocol, its creators said. The project makes clear that it isn't a decentralised autonomous organisation, a type of crypto collective popular among DeFi projects. In July, WLFI holders voted to make the token tradable after the question was put to them by the project's creators. World Liberty Financial said in an X post that the token could begin trading as soon as the end of August. Tim Craig is DL News' Edinburgh-based DeFi Correspondent. Reach out with tips at tim@
Yahoo
14 minutes ago
- Yahoo
Cardinal Health announces the addition of Solaris Health, the country's leading urology MSO, to The Specialty Alliance
Adds over 750 providers to Cardinal Health's multi-specialty MSO platform, The Specialty Alliance Joins with recent urology acquisitions to bolster The Specialty Alliance's leadership in the urology therapeutic area Cardinal Health MSO platforms reach ~3,000 providers in 32 states upon transaction close DUBLIN, Ohio, Aug. 12, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that The Specialty Alliance, its multi-specialty management services organization (MSO) platform, has entered into a definitive agreement to acquire Solaris Health, the country's leading urology MSO, from Lee Equity Partners and Solaris Health physician owners. The transaction accelerates Cardinal Health's multi-specialty growth strategy by extending the reach of The Specialty Alliance, led by CEO James Weber, MD. Taken together with the recent acquisitions of Urology America and Potomac Urology and the just-completed acquisition of Academic Urology & Urogynecology, the acquisition of Solaris Health brings immediate scale to the Urology Alliance within The Specialty Alliance. Cardinal Health will provide approximately $1.9 billion in cash to The Specialty Alliance to enable the acquisition and will own approximately 75% of The Specialty Alliance after its acquisition of Solaris Health. Solaris Health physicians and several members of management will join GI Alliance physician owners and management as equity holders and operators in The Specialty Alliance. Solaris Health supports more than 750 providers across more than 250 practice locations in 14 states, with extensive reach into the local communities they serve. Solaris Health's resilient model and diverse revenue streams result from supporting a broad array of ancillary services, underpinned by a national MSO infrastructure. "Accelerating Specialty growth remains our top priority," said Jason Hollar, CEO, Cardinal Health. "As we previously highlighted, urology is an attractive specialty for us, and we are well-positioned to meet the comprehensive needs of community urologists through the robust combined capabilities of The Specialty Alliance, Specialty Networks and Cardinal Health." "The formation of our Urology Alliance within The Specialty Alliance marks a significant step in expanding our multi-specialty model to meet patient needs across more communities," said Dr. Weber. "As a physician, I know firsthand that integrated, coordinated care is critical to improving outcomes. By bringing Solaris Health's leading urology network into our platform, we're helping specialty providers focus more of their time and energy where it matters most, on their patients. Together, we're advancing a model that empowers physicians and prioritizes the highest standards of care." "Joining The Specialty Alliance's Urology Alliance strengthens our ability to deliver exceptional, patient-centered care through a physician-led, national platform," said Gary Kirsh, MD, CEO, Solaris Health. "This partnership expands our collaborative network of urology providers, allowing physicians to optimize care delivery and enhance patient access to specialized services in their local communities." Following the closing of the transaction, Dr. Kirsh will retire from his role leading Solaris Health and serve as a Senior Advisor to Cardinal Health. "Lee Equity would like to thank Dr. Kirsh for his visionary leadership and congratulate him on building the leading platform in urology," said Christian Chauvet, Partner, Lee Equity. "Dr. Kirsh has been a steadfast champion of independent medicine for his entire career, and we are proud to see Solaris Health and its exceptional physician base continue this legacy by joining the Urology Alliance." Cardinal Health expects the transaction to close by the end of calendar year 2025, subject to closing conditions, including the receipt of required physician and regulatory approvals. The transaction is expected to be slightly accretive to Cardinal Health's non-GAAP earnings per share (EPS) in the first 12 months following close. Cardinal Health expects to include the expected impact to its fiscal year 2026 guidance after the acquisition is completed. Capital Deployment In connection with the announcement of the acquisition, Cardinal Health reaffirmed its disciplined capital allocation framework. The company intends to finance the acquisition with a combination of cash on hand and new debt financing and plans to take a focused approach to paying down debt over the next 18 to 24 months. The company does not expect its deleveraging plans to change its previously outlined share repurchases and continues to expect to be within its targeted leverage range by the end of fiscal 2026. Advisors Goldman Sachs served as financial advisor to Cardinal Health on the acquisition of Solaris Health and Skadden, Arps, Slate, Meagher & Flom LLP and Katten Muchin Rosenman LLP served as legal advisors on the transaction. Centerview Partners served as financial advisor to Solaris Health and McDermott, Will & Emery served as legal advisor on the transaction. Goldman Sachs, BofA Securities and Wells Fargo serve as lead advisors on financing matters related to the acquisition. About Cardinal Health Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at and in our Newsroom. About Solaris Health Solaris Health is the leading U.S. healthcare management company in the urological field. Its affiliated medical practices have over 750 providers who annually care for over one million unique patients in 14 states. These practices and their providers are committed to enhancing access to specialty healthcare and continually improving patient outcomes. Empowering community providers allows them to make sure that every decision they make puts patient care at the forefront. Solaris Health is growing to meet the changing needs of healthcare providers, and to help them develop innovative ways to better deliver value and state-of-the-art care to their patients. Solaris Health is proud to be among the most innovative healthcare management companies in the United States. To learn more, visit About Lee Equity Partners, LLC Lee Equity Partners, LLC is a middle-market private equity firm that partners with businesses in the financial and healthcare services sectors. Over nearly two decades the firm has utilized its thematic based investment strategy and deep sector knowledge to identify and partner with talented management teams to accelerate growth and build market leading businesses. Additional information is available at Contacts Media: Erich Timmerman, and (614) 553-3853 Investors: Matt Sims, and (614) 553-3661 Cautions Concerning Forward-Looking Statements This news release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results or guidance, statements of outlook, and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include risks associated with our planned acquisition of Solaris Health, including the risk that we may not receive required regulatory approval or physician consents or otherwise fail to complete the transaction; the risk that we may fail to realize the anticipated strategic and financial benefits of the acquisition, whether as a result of external factors that may impact the profitability of the business or due to unforeseen challenges. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This news release reflects management's views as of August 12, 2025. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement. Forward-looking statements are aspirational and not guarantees or promises that goals, targets or projections will be met, and no assurance can be given that any commitment, expectation, initiative or plan in this news release can or will be achieved or completed. View original content to download multimedia: SOURCE Cardinal Health Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 minutes ago
- Yahoo
Elon Musk Reacts To Rivian, Lucid Accruing Cash Burn Of $88 Billion As Tesla Remains Only Free Cash Flow Generating Company: 'Harder Than It Looks'
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Elon Musk says that achieving free cash flow with Tesla Inc. (NASDAQ:TSLA), when its company rivals like Lucid Group Inc. (NASDAQ:LCID), Rivian Technologies Inc. (NASDAQ:RIVN) are burning through cash, is difficult. 'Harder Than It Looks,' Says Elon Musk Taking to social media platform X on Sunday, Musk shared his thoughts when replying to a post illustrating a graph that showcased Tesla's positive free cash flow when compared with The same firms that backed Uber, Venmo and eBay are investing in this pre-IPO company disrupting a $1.8T market — "Ex Tesla, the shown companies accrued $88 billion in cash burn," the post said while also adding that Rivian was the most underperforming company in terms of cash burn."This is harder than it looks," Musk said in his response to the Sales Woes Worsen In Multiple Regions Despite the positive cash flow, the company's sales have been lackluster with double-digit declines in multiple regions across the globe, like France, as well as sales falling over 60% in countries like the UK. Tesla sales also fell in California by over 21% despite the company's Model 3 and Model Y topping the sales charts in the state, indicating falling sales domestically for Musk's EV giant. Tesla Secures Texas Ride-Hailing Permit However, Tesla securing a permit to operate ride-hailing services in Texas could provide the company with a major boost as Musk targets the ambitious goal of serving over half of the U.S. population with Tesla Robotaxis by the end of the year. Read Next: 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.30/share. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo Courtesy: This article Elon Musk Reacts To Rivian, Lucid Accruing Cash Burn Of $88 Billion As Tesla Remains Only Free Cash Flow Generating Company: 'Harder Than It Looks' originally appeared on Sign in to access your portfolio